Advertisement

Topics

Google accused of profiting from misleading dementia supplement ads

05:33 EDT 26 Mar 2019 | Pharmafile

Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as much as £38 a month.

The tech giant was reported to have charged between £1 and £3 a click to run adverts for what experts have called ‘pseudomedicnie’.

Users were shown the misleading adverts for ‘brain supplements,’ after searching for terms such as ‘Alzheimer’s pills’ and ‘dementia supplements’. Furthermore the ads often ran ahead of information from reputable organisations.

read more

Original Article: Google accused of profiting from misleading dementia supplement ads

NEXT ARTICLE

More From BioPortfolio on "Google accused of profiting from misleading dementia supplement ads"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dementia
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...